Bone Marrow TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseStem CellsStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsTissue DonorsGraft SurvivalAnemia, AplasticLeukemiaBone and BonesHematologic NeoplasmsTransplantation ChimeraTreatment OutcomeHistocompatibility TestingBusulfanCyclophosphamideCombined Modality TherapyHistocompatibilityKidney TransplantationBone Marrow PurgingLiver TransplantationRecurrenceTransplantationImmunosuppressive AgentsTime FactorsCytomegalovirus InfectionsGraft RejectionLeukemia, Myeloid, AcuteHematopoiesisTransplantation, IsogeneicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisPeripheral Blood Stem Cell TransplantationHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesBone Marrow DiseasesMice, Inbred C57BLImmunocompromised HostCell DifferentiationRemission InductionSurvival RateLymphoma, Non-HodgkinHematologic DiseasesAcute DiseaseImmunosuppressionOpportunistic InfectionsHeart TransplantationLeukemia, MyeloidRadiation ChimeraLymphocyte DepletionLeukocyte TransfusionDisease-Free SurvivalTransplantation ImmunologyFollow-Up StudiesEmbryonic Stem CellsCyclosporineHematopoietic Stem Cell MobilizationMultiple MyelomaBone Marrow ExaminationHLA AntigensMyelodysplastic SyndromesAdult Stem CellsLung TransplantationPrognosisT-LymphocytesFatal OutcomeGranulocyte Colony-Stimulating FactorMelphalanAntineoplastic AgentsColony-Forming Units AssayChemotherapy, AdjuvantMesenchymal Stem Cell TransplantationBone RemodelingBone Marrow NeoplasmsAntigens, CD34EtoposideGraft vs Host ReactionFlow CytometryCells, CulturedSalvage TherapyOrgan TransplantationAspergillosisHodgkin DiseaseCord Blood Stem Cell TransplantationGraft vs Leukemia EffectChimeraMycosesCytarabineSevere Combined ImmunodeficiencyLymphomaActuarial Analysis